Cellectis SA (LTS:0WA2)
€ 1.917 -0.025 (-1.29%) Market Cap: 190.18 Mil Enterprise Value: 138.89 Mil PE Ratio: 0 PB Ratio: 1.64 GF Score: 55/100

Q4 2020 Cellectis SA Earnings Call Transcript

Mar 05, 2021 / 01:00PM GMT
Release Date Price: €14.44 (-13.27%)
Operator

Greetings. Welcome to Cellectis Fourth Quarter and Full Year 2020 Earnings Call. (Operator Instructions) Please note, this conference is being recorded.

At this time, I'll turn the conference over to Simon Harnest, Chief Investment Officer. Simon, you may begin.

Simon Harnest
Cellectis S.A. - SVP of Corporate Strategy & Finance

Thank you, and welcome, everyone, to Cellectis' Fourth Quarter and Full Year Corporate Update and Financial Results Conference Call for the 2020 fiscal year. Joining me on the call today with prepared remarks are Dr. André Choulika, our Chief Executive Officer; Dr. Carrie Brownstein, our Chief Medical Officer; and Eric Dutang, our Chief Financial Officer.

Yesterday evening, Cellectis filed its annual report and issued a press release reporting our financial results for the fourth quarter and year ending December 31, 2020. These reports and press releases are available on our website at cellectis.com.

As a reminder, we will make forward-looking statements regarding Cellectis financial outlook in addition

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot